Pictured: Jedd Wolchok, Alexandra Snyder Charen and Timothy Chan
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Thursday, November 20, 2014

In people with melanoma who respond to the drug ipilimumab, certain mutations make tumors more visible to the immune system.

Michel Sadelain and Prasad Adusumilli
Finding
By Julie Grisham, MS, Science Writer/Editor  |  Wednesday, November 19, 2014

A study in mouse models suggests how modified T cells may be used to treat tumors in the area just outside the lungs.

Pictured: Joao Xavier & Eric Pamer
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Monday, November 10, 2014

Clostridium difficile infections are a growing problem, but MSK researchers are looking for innovative ways to prevent and treat them.

Pictured: Pseudomonas aeruginosa
In the Lab
By Jim Stallard, MA, Writer/Editor  |  Tuesday, October 21, 2014

MSK researchers discover that the body senses and attacks harmful bacteria indirectly after the pathogens cause stress within the cells.

Pictured: Experimental Brain Tumor
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, September 18, 2014

Researchers have engineered a gene into therapeutic cells that allows them to turn off tumor growth if some of the cells become cancerous.

Pictured: Richard O’Reilly
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Thursday, July 31, 2014

A study shows that treatment of severe combined immunodeficiency (SCID) with stem cell transplantation is very effective, especially if done early.

Pictured: Activated macrophage
In the Lab
By Jennifer Bell, PhD  |  Thursday, June 5, 2014

Researchers are exploring a mysterious population of immune cells that live within tumors and can help the cancer grow and spread.

Pictured: Jedd Wolchok
MSK at ASCO
By Media Staff  |  Wednesday, June 4, 2014

Our experts offer their perspective in major media outlets on recent research into drug- and cell-based immunotherapies for cancer.

Pictured: Helen McArthur
In the Clinic
By Julie Grisham, MS, Science Writer/Editor  |  Tuesday, June 3, 2014

The treatment combines a technique called cryoablation, or freezing of the tumor, with an immunotherapy drug.

Pictured: Jedd Wolchok
In the News
By Jim Stallard, MA, Writer/Editor  |  Friday, May 2, 2014

Memorial Sloan Kettering physician-scientist Jedd Wolchok describes striking advances in cancer immunotherapy in New York Times and Scientific American.

Pictured: Macrophage & Tumor Cells
Feature
By Eva Kiesler, PhD, Science Writer/Editor  |  Thursday, May 1, 2014

Approaches used for research into the social lives of bacteria can also be used to explore how tumors behave and evolve.

Pictured: Susan Prockop & Lucas T.
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Thursday, March 6, 2014

Memorial Sloan Kettering physician-scientists have prevented a dangerous complication of stem cell transplantation using immune cells donated from a third party.

Pictured: Marcel van den Brink & Robert Jenq
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Monday, March 3, 2014

Research suggests that the presence of a type of bacteria called Blautia, which occurs naturally in the body, may prevent graft-versus-host disease, a potentially fatal side effect of bone marrow and stem cell transplants.

 Pictured: Cancer cell on blood vessel
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Thursday, February 27, 2014

Researchers have gained new understanding of how tumors metastasize by studying the behavior of exceptional breast and lung cancer cells that are capable of entering the brain and surviving there.

Pictured: Renier Brentjens, Isabelle Rivière & Michel Sadelain
In the Clinic
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, February 20, 2014

A new study evaluating a cell-based immune therapy to treat an aggressive type of leukemia — the largest study of its kind to date — reports that 88 percent of patients responded to the treatment.

Center News

Stay Informed

Get the latest information about cancer care and research every month.